SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-01-001077
Filing Date
2001-03-29
Accepted
2001-03-29 00:00:00
Documents
7
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K NOVAVAX, INC. w46163e10-k.htm 10-K 456121
2 CERTIFICATE OF AMENDMENT DATED DECEMBER 18, 2000 w46163ex3-4.htm EX-3.4 3075
3 LIST OF SUSIDIARIES w46163ex21.htm EX-21 583
4 CONSENT OF ERNST & YOUNG LLP w46163ex23-1.htm EX-23.1 1501
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP w46163ex23-2.htm EX-23.2 752
6 w46163pi5-178.gif GRAPHIC 1265
7 w46163pi5-110.gif GRAPHIC 1217
  Complete submission text file 0000950133-01-001077.txt   466738
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 1583391
SIC: 2836 Biological Products, (No Diagnostic Substances)